Terms: = Prostate cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG
93 results:
1. A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [
Lv J; Yu H; Yin H; Shi Y; Shi H
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):919-927. PubMed ID: 37940684
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of holmium laser, bipolar and conventional monopolar transurethral resection of bladder tumour in primary non-muscle invasive bladder cancer.
Elmekawy S; Taha DE; Nabeeh HE; Ibrahim A; Zeid AE; Abdelbaky T
J Pak Med Assoc; 2023 Apr; 73(Suppl 4)(4):S251-S256. PubMed ID: 37482868
[TBL] [Abstract] [Full Text] [Related]
3. Pretreatment information-aided automatic segmentation for online magnetic resonance imaging-guided prostate radiotherapy.
Yang B; Liu Y; Zhu J; Lu N; Dai J; Men K
Med Phys; 2024 Feb; 51(2):922-932. PubMed ID: 37449545
[TBL] [Abstract] [Full Text] [Related]
4. Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain).
Palomar-Cros A; Straif K; Romaguera D; Aragonés N; Castaño-Vinyals G; Martin V; Moreno V; Gómez-Acebo I; Guevara M; Aizpurua A; Molina-Barceló A; Jiménez-Moleón JJ; Tardón A; Contreras-Llanes M; Marcos-Gragera R; Huerta JM; Pérez-Gómez B; Espinosa A; Hernández-Segura N; Obón-Santacana M; Alonso-Molero J; Burgui R; Amiano P; Pinto-Carbó M; Olmedo-Requena R; Fernández-Tardón G; Santos-Sánchez V; Fernández de Larrea-Baz N; Fernández-Villa T; Casabonne D; Dierssen-Sotos T; Ardanaz E; Dorronsoro A; Pollán M; Kogevinas M; Lassale C
Int J Cancer; 2023 Sep; 153(5):979-993. PubMed ID: 37323037
[TBL] [Abstract] [Full Text] [Related]
5. Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancer.
Roy S; Wallis CJD; Morgan SC; Kishan AU; Le ATT; Malone J; Sun Y; Spratt DE; Saad F; Malone S
Prostate; 2023 Jul; 83(10):912-921. PubMed ID: 37071764
[TBL] [Abstract] [Full Text] [Related]
6. Tumor testing and treatment patterns in veterans with metastatic castration-resistant prostate cancer.
Hung A; Candelieri D; Li Y; Alba P; Robison B; Agiri F; Perez C; Lee KM; Maxwell KN; Li W; Aggarwal H; Pridgen K; Reed SD; DuVall S; Wong YN; Lynch JA
Semin Oncol; 2023; 50(1-2):11-24. PubMed ID: 37055240
[TBL] [Abstract] [Full Text] [Related]
7. Adjusting the duration of androgen deprivation therapy (ADT) based on nadir PSA for high risk localized prostate cancer patients treated with definitive external beam radiation therapy and ADT.
Ayoub Z; Khader J; Bulbul M; Khauli RB; Andraos TY; Shamseddine A; Mukherji D; Geara FB
BMC Urol; 2022 Dec; 22(1):204. PubMed ID: 36503556
[TBL] [Abstract] [Full Text] [Related]
8. Medium-term Oncological Efficacy and Patient-reported Outcomes After Focal High-intensity Focused Ultrasound: The FOXPRO Trial.
Westhoff N; Ernst R; Kowalewski KF; Derigs F; Neuberger M; Nörenberg D; Popovic ZV; Ritter M; Stephan Michel M; von Hardenberg J
Eur Urol Focus; 2023 Mar; 9(2):283-290. PubMed ID: 36344395
[TBL] [Abstract] [Full Text] [Related]
9. Racial Analysis of Clinical and Biochemical Outcomes in Patients With prostate cancer Treated With Low-Dose-Rate Brachytherapy.
Kerans SJ; Samanta S; Vyfhuis MAL; Guerrero M; Bang CK; Mishra MV; Rana Z; Amin PP; Kwok Y; Naslund MJ; Molitoris JK
Int J Radiat Oncol Biol Phys; 2023 May; 116(1):87-95. PubMed ID: 36336224
[TBL] [Abstract] [Full Text] [Related]
10. Urethral and bladder neck stenosis after thulium laser enucleation of the prostate: Analysis of risk factors in a series of 1003 patients.
Castellani D; Antonucci M; Signoretti M; Cipriani C; Vittori M; Bertolo R; Gasparri L; Dellabella M; Bove P
Andrologia; 2022 Oct; 54(9):e14523. PubMed ID: 35789109
[TBL] [Abstract] [Full Text] [Related]
11. Predictive role of node-rads score in patients with prostate cancer candidates for radical prostatectomy with extended lymph node dissection: comparative analysis with validated nomograms.
Lucciola S; Pisciotti ML; Frisenda M; Magliocca F; Gentilucci A; Del Giudice F; Canale V; Scarrone E; Busetto GM; Carrieri G; Cormio L; Carbone A; Pastore A; De Nunzio C; Tubaro A; Leonardo C; Franco G; Di Pierro GB; Salciccia S; Sciarra A; Panebianco V
Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):379-387. PubMed ID: 35732820
[TBL] [Abstract] [Full Text] [Related]
12. prostate cancer incidence and survival in relation to prostate cancer as second cancer in relatives.
Zheng G; Sundquist J; Sundquist K; Ji J
Cancer Med; 2022 May; 11(10):2117-2124. PubMed ID: 35312170
[TBL] [Abstract] [Full Text] [Related]
13. mRNA and small RNA gene expression changes in peripheral blood to detect internal Ra-223 exposure.
Ostheim P; Miederer M; Schreckenberger M; Nestler T; Hoffmann MA; Lassmann M; Eberlein U; Barsegian V; Rump A; Majewski M; Port M; Abend M
Int J Radiat Biol; 2022; 98(5):900-912. PubMed ID: 34882512
[TBL] [Abstract] [Full Text] [Related]
14. Automatic identification of suspicious bone metastatic lesions in bone scintigraphy using convolutional neural network.
Liu Y; Yang P; Pi Y; Jiang L; Zhong X; Cheng J; Xiang Y; Wei J; Li L; Yi Z; Cai H; Zhao Z
BMC Med Imaging; 2021 Sep; 21(1):131. PubMed ID: 34481459
[TBL] [Abstract] [Full Text] [Related]
15. Integration of quantitative diffusion kurtosis imaging and prostate specific antigen in differential diagnostic of prostate cancer.
Yao W; Zheng J; Han C; Lu P; Mao L; Liu J; Wang G; Zou S; Li L; Xu Y
Medicine (Baltimore); 2021 Sep; 100(35):e27144. PubMed ID: 34477170
[TBL] [Abstract] [Full Text] [Related]
16. Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database.
Ptáková N; Martínek P; Holubec L; Janovský V; Vančurová J; Grossmann P; Navarro PA; Rodriguez Moreno JF; Alaghehbandan R; Hes O; Májek O; Pešek M; Michal M; Ondič O
Genes Chromosomes Cancer; 2021 Jul; 60(7):474-481. PubMed ID: 33583086
[TBL] [Abstract] [Full Text] [Related]
17. Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database.
Yirga A; Oyekunle T; Howard LE; De Hoedt AM; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Taioli E; Fowke JH; Klaanssen Z; Freedland SJ; Vidal AC
Cancer Causes Control; 2021 Feb; 32(2):189-197. PubMed ID: 33392907
[TBL] [Abstract] [Full Text] [Related]
18. [Expression of cluster of differentiation 74 in prostate cancer and its clinical significance].
Tian ZB; Qi WC; Jin RS
Zhonghua Nan Ke Xue; 2020 Feb; 26(2):123-127. PubMed ID: 33346414
[TBL] [Abstract] [Full Text] [Related]
19. Latent prostate cancer among Japanese males: a bibliometric study of autopsy reports from 1980-2016.
Takeshima Y; Suzuki M; Miyakawa J; Tsuru I; Yamada Y; Nakamura M; Sato Y; Kawai T; Yamada D; Morikawa T; Kume H
Jpn J Clin Oncol; 2021 Jan; 51(1):156-159. PubMed ID: 32875336
[TBL] [Abstract] [Full Text] [Related]
20. Impact of non-adherence to radiotherapy on 1-year survival in cancer patients in Catalonia, Spain.
Borras JM; Font R; Solà J; Macia M; Tuset V; Arenas M; Eraso A; Verges R; Farré N; Pedro A; Mollà M; Algara M; Solé JM; Mira M; Espinàs JA
Radiother Oncol; 2020 Oct; 151():200-205. PubMed ID: 32771615
[TBL] [Abstract] [Full Text] [Related]
[Next]
